Answers are grounded in this paper and cite their sources.
Introduction To evaluate the effectiveness and safety of plasmapheresis in cases complicated by severe alloimmunization. Methods We reviewed multiple studies from databases like Medline, Embase, and Cochrane, looking specifically for research on ‘Rhesus incompatibility’, ‘plasmapheresis’, and ‘pregnancy’. After narrowing down, we included 46 studies that met our criteria to see how this treatment affected both prenatal and postnatal health. Results Out of 208 pregnancies analysed, about 22.1% sadly resulted in foetal loss, with one neonatal death. However, starting plasmapheresis as early as 3 weeks helped delay or avoid the need for Intrauterine blood transfusions in cases of severe foetal anaemia. Most of the babies born (77.4%) had positive outcomes, although many needed phototherapies after birth. Combining IVIG with plasmapheresis appears to be safe, with good postnatal outcomes. Conclusions Plasmapheresis shows promise as a treatment for severe Rhesus sensitisation, potentially reducing the need for Intrauterine transfusions and improving newborn outcomes. More studies are needed to refine treatment protocols and confirm these early findings.
No takes yet. Share an insight, caveat, or question.
Abdallah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: